Zinc is a potent and specific inhibitor of IFN-λ3 signalling

[1]  Kristina M. Cook,et al.  A substrate-driven allosteric switch that enhances PDI catalytic activity , 2016, Nature Communications.

[2]  R. Diefenbach,et al.  Abalone Hemocyanin Blocks the Entry of Herpes Simplex Virus 1 into Cells: a Potential New Antiviral Strategy , 2015, Antimicrobial Agents and Chemotherapy.

[3]  Charles M. Rice,et al.  Corrigendum: A diverse range of gene products are effectors of the type I interferon antiviral response , 2015, Nature.

[4]  V. Wong,et al.  Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease , 2015, Nature Communications.

[5]  M. Diamond,et al.  Commensal microbes and interferon-λ determine persistence of enteric murine norovirus infection , 2015, Science.

[6]  Maxim N. Artyomov,et al.  Interferon-λ cures persistent murine norovirus infection in the absence of adaptive immunity , 2015, Science.

[7]  M. Castro,et al.  Interferon response and respiratory virus control are preserved in bronchial epithelial cells in asthma. , 2014, The Journal of allergy and clinical immunology.

[8]  M. Battegay,et al.  IL-28B is a Key Regulator of B- and T-Cell Vaccine Responses against Influenza , 2014, PLoS pathogens.

[9]  J. George,et al.  Hepatitis C virus infection mediates cholesteryl ester synthesis to facilitate infectious particle production. , 2014, The Journal of general virology.

[10]  Siyuan Ding,et al.  Peroxisomal MAVS activates IRF1-mediated IFN-λ production , 2014, Nature Immunology.

[11]  Steven H Kleinstein,et al.  Dynamic expression profiling of type I and type III interferon‐stimulated hepatocytes reveals a stable hierarchy of gene expression , 2014, Hepatology.

[12]  E. Galmozzi,et al.  Nonsynonymous variant Pro70Ser (rs117648444) in IFNL4 gene identifies carriers of the rs368234815 ΔG allele with higher HCV RNA decline during the first 4 weeks of pegylated interferon and ribavirin therapy in HCV-1 patients. , 2014, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[13]  C. Rice,et al.  Interferon lambda alleles predict innate antiviral immune responses and hepatitis C virus permissiveness. , 2014, Cell host & microbe.

[14]  D. Booth,et al.  Hepatic metallothionein expression in chronic hepatitis C virus infection is IFNL3 genotype-dependent , 2014, Genes and Immunity.

[15]  A. Iwasaki,et al.  Epigenetic Reprogramming of the Type III Interferon Response Potentiates Antiviral Activity and Suppresses Tumor Growth , 2014, PLoS biology.

[16]  S. Polyak,et al.  Independent, parallel pathways to CXCL10 induction in HCV-infected hepatocytes. , 2013, Journal of hepatology.

[17]  L. Rink,et al.  Differential Regulation of TLR-Dependent MyD88 and TRIF Signaling Pathways by Free Zinc Ions , 2013, The Journal of Immunology.

[18]  Daniel W. A. Buchan,et al.  Scalable web services for the PSIPRED Protein Analysis Workbench , 2013, Nucleic Acids Res..

[19]  Z. Lee,et al.  The interaction between CXCL10 and cytokines in chronic inflammatory arthritis. , 2013, Autoimmunity reviews.

[20]  D. Nebert,et al.  ZIP8 regulates host defense through zinc-mediated inhibition of NF-κB. , 2013, Cell reports.

[21]  Qingrui Yang,et al.  Serum IFN-λ1 is abnormally elevated in rheumatoid arthritis patients , 2013, Autoimmunity.

[22]  Barbara Rehermann,et al.  A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus , 2013, Nature Genetics.

[23]  A. Folgori,et al.  IL‐29 is the dominant type III interferon produced by hepatocytes during acute hepatitis C virus infection , 2012, Hepatology.

[24]  Chunyu Liu,et al.  Two Gene Co-expression Modules Differentiate Psychotics and Controls , 2012, Molecular Psychiatry.

[25]  V. Adam,et al.  Mammalian metallothioneins: properties and functions. , 2012, Metallomics : integrated biometal science.

[26]  J. Niu,et al.  IL28B Genetic Variation Is Associated with Spontaneous Clearance of Hepatitis C Virus, Treatment Response, Serum IL-28B Levels in Chinese Population , 2012, PloS one.

[27]  J. Benito,et al.  Impact of IL28B gene polymorphisms on interferon-λ3 plasma levels during pegylated interferon-α/ribavirin therapy for chronic hepatitis C in patients coinfected with HIV. , 2012, Journal of Antimicrobial Chemotherapy.

[28]  Qisheng Li,et al.  HCV infection induces a unique hepatic innate immune response associated with robust production of type III interferons. , 2012, Gastroenterology.

[29]  A. Hausrath,et al.  Zinc enhances adiponectin oligomerization to octadecamers but decreases the rate of disulfide bond formation , 2012, BioMetals.

[30]  M. Nakanishi,et al.  Genetic Variation of the IL-28B Promoter Affecting Gene Expression , 2011, PloS one.

[31]  E. Lourenço,et al.  Interferon-lambda1 induces peripheral blood mononuclear cell-derived chemokines secretion in patients with systemic lupus erythematosus: its correlation with disease activity , 2011, Arthritis research & therapy.

[32]  Haiyan Liu,et al.  Structure-based de novo prediction of zinc-binding sites in proteins of unknown function , 2011, Bioinform..

[33]  Julia E. Vogt,et al.  Interferon-induced gene expression is a stronger predictor of treatment response than IL28B genotype in patients with hepatitis C. , 2011, Gastroenterology.

[34]  Jacques Fellay,et al.  IL28B genotype is associated with differential expression of intrahepatic interferon‐stimulated genes in patients with chronic hepatitis C , 2010, Hepatology.

[35]  A. Wlodawer,et al.  Crystal structure of the complex of human interferon-lambda1 with its high affinity receptor interferon-lambdaR1. , 2010 .

[36]  A. Wlodawer,et al.  Crystal Structure of Human Interferon-λ1 in Complex with Its High-Affinity Receptor Interferon-λR1 , 2010, Journal of Molecular Biology.

[37]  S. Smirnov,et al.  Lambda Interferon Is the Predominant Interferon Induced by Influenza A Virus Infection In Vivo , 2010, Journal of Virology.

[38]  Leiliang Zhang,et al.  Hepatitis C virus regulates transforming growth factor beta1 production through the generation of reactive oxygen species in a nuclear factor kappaB-dependent manner. , 2010, Gastroenterology.

[39]  A. C. Looman,et al.  Despite IFN-λ receptor expression, blood immune cells, but not keratinocytes or melanocytes, have an impaired response to type III interferons: implications for therapeutic applications of these cytokines , 2009, Genes and Immunity.

[40]  A. Prasad,et al.  Zinc: role in immunity, oxidative stress and chronic inflammation , 2009, Current opinion in clinical nutrition and metabolic care.

[41]  David B. Goldstein,et al.  Genetic variation in IL28B and spontaneous clearance of hepatitis C virus , 2009, Nature.

[42]  Thomas Berg,et al.  IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy , 2009, Nature Genetics.

[43]  A. Koike,et al.  Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C , 2009, Nature Genetics.

[44]  Jacques Fellay,et al.  Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance , 2009, Nature.

[45]  S. Paludan,et al.  Interferon-λ Is Functionally an Interferon but Structurally Related to the Interleukin-10 Family* , 2009, The Journal of Biological Chemistry.

[46]  Carlos Prieto,et al.  Human Gene Coexpression Landscape: Confident Network Derived from Tissue Transcriptomic Profiles , 2008, PloS one.

[47]  J. Ceuppens,et al.  Type III IFN‐λ mRNA expression in sputum of adult and school‐aged asthmatics , 2008, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[48]  Edward J Oakeley,et al.  Interferon signaling and treatment outcome in chronic hepatitis C , 2008, Proceedings of the National Academy of Sciences.

[49]  A. Prasad,et al.  Zinc in Human Health: Effect of Zinc on Immune Cells , 2008, Molecular medicine.

[50]  T. Michiels,et al.  IFN-Lambda (IFN-λ) Is Expressed in a Tissue-Dependent Fashion and Primarily Acts on Epithelial Cells In Vivo , 2008, PLoS pathogens.

[51]  Jessica C. Ebert,et al.  Robust recognition of zinc binding sites in proteins , 2007, Protein science : a publication of the Protein Society.

[52]  V. Sobolev,et al.  Prediction of transition metal‐binding sites from apo protein structures , 2007, Proteins.

[53]  A. Nielsen,et al.  Type III Interferon (IFN) Induces a Type I IFN-Like Response in a Restricted Subset of Cells through Signaling Pathways Involving both the Jak-STAT Pathway and the Mitogen-Activated Protein Kinases , 2007, Journal of Virology.

[54]  T. Satoh,et al.  Interferonbeta-induced changes in metallothionein expression and subcellular distribution of zinc in HepG2 cells. , 2006, Cytokine.

[55]  Sangsoo Kim,et al.  Gene expression Differential coexpression analysis using microarray data and its application to human cancer , 2005 .

[56]  R. Ueda,et al.  Novel Type of Hepatitis B Virus Mutation: Replacement Mutation Involving a Hepatocyte Nuclear Factor 1 Binding Site Tandem Repeat in Chronic Hepatitis B Virus Genotype E , 2005, Journal of Virology.

[57]  W. Achanzar,et al.  Interferon alpha induction of metallothionein in rat liver is not linked to interleukin-1, interleukin-6, or tumor necrosis factor alpha. , 2005, Experimental and molecular pathology.

[58]  R. Bartenschlager,et al.  Production of infectious hepatitis C virus in tissue culture from a cloned viral genome , 2005, Nature Medicine.

[59]  M. Hällbrink,et al.  Metallic Zinc Reduction of Disulfide Bonds between Cysteine Residues in Peptides and Proteins , 2005, International Journal of Peptide Research and Therapeutics.

[60]  T. Ganz,et al.  Interleukin-6 regulates the zinc transporter Zip14 in liver and contributes to the hypozincemia of the acute-phase response. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[61]  J. T. Saari,et al.  Abrogation of Nuclear Factor-κB Activation Is Involved in Zinc Inhibition of Lipopolysaccharide-Induced Tumor Necrosis Factor-α Production and Liver Injury , 2004 .

[62]  Bo Zhang,et al.  Activity of Metal-Responsive Transcription Factor 1 by Toxic Heavy Metals and H2O2 In Vitro Is Modulated by Metallothionein , 2003, Molecular and Cellular Biology.

[63]  Tom H. Pringle,et al.  The human genome browser at UCSC. , 2002, Genome research.

[64]  A. Prasad.  Effects of zinc deficiency on Th1 and Th2 cytokine shifts. , 2000, The Journal of infectious diseases.

[65]  U. Jakob,et al.  Chaperone Activity with a Redox Switch , 1999, Cell.

[66]  L. Rink,et al.  Zinc supplementation reconstitutes the production of interferon-alpha by leukocytes from elderly persons. , 1997, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[67]  M. Mori,et al.  The possible role of zinc and metallothionein in the liver on the therapeutic effect of IFN-α to hepatitis C patients , 1997, Biological Trace Element Research.

[68]  A. Hruza,et al.  Zinc mediated dimer of human interferon-alpha 2b revealed by X-ray crystallography. , 1996, Structure.

[69]  Luchuan Liang,et al.  Oxidative Stress Activates Metal-responsive Transcription Factor-1 Binding Activity , 1996, The Journal of Biological Chemistry.

[70]  T. Yoshida,et al.  Metallothionein synthesis induced by interferon alpha/beta in mice of various zinc status. , 1996, The Tohoku journal of experimental medicine.

[71]  J. Berg,et al.  The Galvanization of Biology: A Growing Appreciation for the Roles of Zinc , 1996, Science.

[72]  H. Hojo,et al.  Differential induction of metallothionein synthesis by interleukin-6 and tumor necrosis factor-alpha in rat tissues. , 1994, International journal of immunopharmacology.

[73]  R. Cousins,et al.  Interleukin 6 regulates metallothionein gene expression and zinc metabolism in hepatocyte monolayer cultures. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[74]  R. Cousins,et al.  Tissue‐specific regulation of zinc metabolism and metallothionein genes by interleukin 1 , 1988, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[75]  M. Rousset,et al.  The human colon carcinoma cell lines HT-29 and Caco-2: two in vitro models for the study of intestinal differentiation. , 1986, Biochimie.

[76]  R. Pekarek,et al.  Effect of Acute Infection and Endotoxemia on Zinc Absorption in the Rat , 1975, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[77]  T. Michiels,et al.  IFN-lambda ( IFN-lambda ) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo , 2018 .

[78]  G. Engelhardt,et al.  The biochemical effects of extracellular Zn(2+) and other metal ions are severely affected by their speciation in cell culture media. , 2015, Metallomics : integrated biometal science.

[79]  L. Rink,et al.  Zinc signals and immune function , 2014, BioFactors.

[80]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[81]  Antonio Rosato,et al.  Counting the zinc-proteins encoded in the human genome. , 2006, Journal of proteome research.

[82]  C. McClain,et al.  Abrogation of nuclear factor-kappaB activation is involved in zinc inhibition of lipopolysaccharide-induced tumor necrosis factor-alpha production and liver injury. , 2004, The American journal of pathology.

[83]  Koichi Suzuki,et al.  Properties and Functions , 1973 .